You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動|諾和諾德盤前跌近4% 新型減肥藥臨牀試驗數據不及預期
格隆匯 06-23 16:11
諾和諾德(NVO.US)盤前跌近4%,報70.87美元。消息面上,諾和諾德披露其新型減肥藥物CagriSema兩項Ⅲ期臨牀試驗完整數據,顯示該藥物在減重效果和代謝指標改善方面表現積極,但胃腸道副作用發生率高於安慰劑組。這一結果與此前公佈的階段性數據基本一致,但未能完全達到資本市場預期。諾和諾德此前在芝加哥舉行的美國糖尿病協會年會上公佈了長達68周的臨牀研究細節,接受CagriSema治療的超重或肥胖非糖尿病患者平均減重約23%,2型糖尿病合併超重患者減重15.8%。(格隆匯)
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account